CURRENT ALZHEIMER RESEARCH, vol.19, no.1, pp.84-93, 2022 (SCI-Expanded)
Article / Article
CURRENT ALZHEIMER RESEARCH
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, Chemical Abstracts Core, EMBASE, MEDLINE, Psycinfo
Alzheimer's disease, MALDI-TOF-MS, screening tool, microaffinity chromatography, affinity capture resins, kappa light chain, ratio, lambda light chain ratio, PLASMA NEUROFILAMENT LIGHT, FOLLOW-UP, ELECTROPHORESIS, BIOMARKERS, PROTEINS, QUANTIFICATION, PURIFICATION, PROGNOSIS, DISCOVERY, DIAGNOSIS
Istanbul University Affiliated:
Background: Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss and cognitive impairment. The diagnosis of Alzheimer's disease according to symptomatic events is still a puzzling task. Developing a biomarker-based, low-cost, and high-throughput test, readily applicable in clinical laboratories, dramatically impacts the rapid and reliable detection of the disease.